NorthCrest Asset Manangement’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.32M | Sell |
11,554
-349
| -3% | -$191K | 0.17% | 121 |
|
|
2025
Q1 | $7.55M | Buy |
11,903
+557
| +5% | +$353K | 0.23% | 109 |
|
|
2024
Q4 | $8.08M | Buy |
11,346
+270
| +2% | +$192K | 0.24% | 103 |
|
|
2024
Q3 | $11.6M | Buy |
11,076
+271
| +3% | +$285K | 0.35% | 83 |
|
|
2024
Q2 | $11.4M | Buy |
10,805
+256
| +2% | +$269K | 0.38% | 81 |
|
|
2024
Q1 | $10.2M | Buy |
10,549
+143
| +1% | +$138K | 0.35% | 88 |
|
|
2023
Q4 | $9.14M | Sell |
10,406
-20
| -0.2% | -$17.6K | 0.35% | 88 |
|
|
2023
Q3 | $8.58M | Sell |
10,426
-21
| -0.2% | -$17.3K | 0.35% | 91 |
|
|
2023
Q2 | $7.51M | Buy |
10,447
+132
| +1% | +$94.8K | 0.3% | 106 |
|
|
2023
Q1 | $8.48M | Buy |
10,315
+516
| +5% | +$424K | 0.35% | 96 |
|
|
2022
Q4 | $7.07M | Sell |
9,799
-609
| -6% | -$439K | 0.4% | 89 |
|
|
2022
Q3 | $7.17M | Buy |
10,408
+88
| +0.9% | +$60.6K | 0.39% | 94 |
|
|
2022
Q2 | $6.1M | Sell |
10,320
-151
| -1% | -$89.3K | 0.31% | 109 |
|
|
2022
Q1 | $7.31M | Buy |
10,471
+582
| +6% | +$406K | 0.35% | 101 |
|
|
2021
Q4 | $6.25M | Buy |
+9,889
| New | +$6.25M | 0.34% | 92 |
|